An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
The COVID-19 pandemic is one of the greatest threats to human health in the 21st century
with more than 257 million cases and over 5.17 million deaths reported worldwide (as of …
with more than 257 million cases and over 5.17 million deaths reported worldwide (as of …
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European …
S Cesaro, P Ljungman, M Mikulska, HH Hirsch… - Leukemia, 2022 - nature.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel virus that spread
worldwide from 2019 causing the Coronavirus disease 19 (COVID-19) pandemic. SARS …
worldwide from 2019 causing the Coronavirus disease 19 (COVID-19) pandemic. SARS …
High-dose dexamethasone and oxygen support strategies in intensive care unit patients with severe COVID-19 acute hypoxemic respiratory failure: the COVIDICUS …
Importance The benefit of high-dose dexamethasone and oxygenation strategies vs
standard of care for patients with severe acute hypoxemic respiratory failure (AHRF) caused …
standard of care for patients with severe acute hypoxemic respiratory failure (AHRF) caused …
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial
Purpose We compared dexamethasone 12 versus 6 mg daily for up to 10 days in patients
with coronavirus disease 2019 (COVID-19) and severe hypoxaemia in the international …
with coronavirus disease 2019 (COVID-19) and severe hypoxaemia in the international …
Dexamethasone: insights into pharmacological aspects, therapeutic mechanisms, and delivery systems
VS Madamsetty, R Mohammadinejad… - ACS biomaterials …, 2022 - ACS Publications
Dexamethasone (DEX) has been widely used to treat a variety of diseases, including
autoimmune diseases, allergies, ocular disorders, cancer, and, more recently, COVID-19 …
autoimmune diseases, allergies, ocular disorders, cancer, and, more recently, COVID-19 …
Randomised clinical trials in critical care: past, present and future
Randomised clinical trials (RCTs) are the gold standard for providing unbiased evidence of
intervention effects. Here, we provide an overview of the history of RCTs and discuss the …
intervention effects. Here, we provide an overview of the history of RCTs and discuss the …
Pharmacological treatment of COVID-19: an opinion paper
A García-Lledó, J Gómez-Pavón… - Revista Española …, 2021 - pmc.ncbi.nlm.nih.gov
The precocity and efficacy of the vaccines developed so far against COVID-19 has been the
most significant and saving advance against the pandemic. The development of vaccines …
most significant and saving advance against the pandemic. The development of vaccines …
[HTML][HTML] Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised …
RECOVERY Collaborative Group - Lancet (London, England), 2023 - ncbi.nlm.nih.gov
Background Low-dose corticosteroids have been shown to reduce mortality for patients with
COVID-19 requiring oxygen or ventilatory support (non-invasive mechanical ventilation …
COVID-19 requiring oxygen or ventilatory support (non-invasive mechanical ventilation …
COVID-19 annual update: a narrative review
M Biancolella, VL Colona, L Luzzatto, JL Watt… - Human genomics, 2023 - Springer
Three and a half years after the pandemic outbreak, now that WHO has formally declared
that the emergency is over, COVID-19 is still a significant global issue. Here, we focus on …
that the emergency is over, COVID-19 is still a significant global issue. Here, we focus on …
Comparison of COVID-19 induced respiratory failure and typical ARDS: similarities and differences
S Lu, X Huang, R Liu, Y Lan, Y Lei, F Zeng… - Frontiers in …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is a predominantly respiratory infectious disease
caused by novel coronavirus infection (SARS-CoV-2), respiratory failure is the main clinical …
caused by novel coronavirus infection (SARS-CoV-2), respiratory failure is the main clinical …